MARATTO

article · Innovation in Aging

“[CERVICAL CANCER], NOT AT THIS AGE…”: TREATMENT EXPERIENCES OF OLDER WOMEN WITH ADVANCED CERVICAL CANCER

2024Open accessUniversity of Nigeria

Abstract

Abstract Background Cervical cancer (CC) is 90% preventable with the HPV vaccine against sub-types 16 and 18, yet an estimated 21 women die every day from CC, and 7,968 die annually in Nigeria. Most of the women diagnosed with CC are older women, yet the gerontological aspect of CC among this population is largely scarce. Older women living with CC are at risk of undertreatment and are most likely to report the worst prognosis. This phenomenological study is aimed at understanding the treatment experiences of older women living with stage IV CC and their meaning-making of this incurable disease. Method Using interpretive phenomenological analysis (IPA), 16 older women (50 – 85 years) with advanced CC were recruited. Data was collected through semi-structured interviews, and the six steps of IPA were used for analysis. Results Four identified themes: “[cervical cancer], not at this age, not at any age anyway but at this age to me is even worse”, “He [the doctor] talked about surgery but because of my age, surgery was moved out”, “There is a need for support and to be loved” and “When someone’s [cancer] is palliative, take it as palliative, when it is critical treat it as such. Don’t treat palliative and leave critical aside”. Conclusion This study provided a gerontological insight into the lived experiences of these older women. As the world is working to eliminate cervical cancer with the human papillomavirus vaccine, older women who already have advanced cervical cancer should not be forgotten.

Research topics

  • Cervical Cancer and HPV Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/geroni/igae098.4295

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.